Corporate Announcement
Security Code : 530019    Company : JUBLPHARMA    
 
Announces Q3 Results, Results Press Release, Investors Presentation & Limited Review Report for Dec 31, 2014Download PDF
  Exchange Disseminated Time     
Jubilant Life Sciences Ltd has announced the following results for the quarter ended December 31, 2014:

The Un-Audited Standalone results for the Quarter ended December 31, 2014

The Company has posted a net (loss) of Rs. (84.80) million for the quarter ended December 31, 2014 as compared to Net Profit of Rs. 1645.20 million for the quarter ended December 31, 2013. Total Income has decreased from Rs. 9574.10 million for the quarter ended December 31, 2013 to Rs. 7411.90 million for the quarter ended December 31, 2014.

The Consolidated Results are as follows:

The Unaudited Consolidated results for the Quarter ended December 31, 2014

The Group has posted a net profit/(loss) after taxes, minority interest and share of profit/loss of associates of Rs. (111.60) million for the quarter ended December 31, 2014 as compared to net profit of Rs. 1434.30 million for the quarter ended December 31, 2013. Total Income has increased from Rs. 14484.90 million for the quarter ended December 31, 2013 to Rs. 14515.30 million for the quarter ended December 31, 2014.
 

Disclaimer

Back To Announcements